HWAM
ALT icon

Hennion & Walsh Asset Management’s Altimmune ALT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.13M Buy
744,997
+226,799
+44% +$696K 0.06% 363
2026
Q2 		$1.58M Buy
518,198
+316,209
+157% +$944K 0.05% 445
2026
Q1 		$622K Sell
201,989
-12,643
-6% -$53.7K 0.02% 647
2025
Q4 		$775K Buy
214,632
+29,057
+16% +$127K 0.03% 586
2025
Q3 		$700K Sell
185,575
-3,380
-2% -$13.1K 0.03% 605
2025
Q2 		$731K Sell
188,955
-8,729
-4% -$47.2K 0.03% 567
2025
Q1 		$988K Sell
197,684
-7,906
-4% -$50.1K 0.04% 476
2024
Q4 		$1.48M Buy
205,590
+31,482
+18% +$241K 0.07% 358
2024
Q3 		$1.07M Buy
174,108
+44,832
+35% +$304K 0.05% 438
2024
Q2 		$860K Buy
+129,276
New +$954K 0.04% 459

Other funds holding ALT

BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
MWP
Meriwether Wealth & Planning Minden, Louisiana $222M AUM 15.77% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Hennion & Walsh Asset Management's ALT Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its Altimmune (ALT) stake by 44% in Q3 2026, buying an estimated $696K and bringing the position to 744,997 shares worth $2.13M. The position accounts for 0.06% of the portfolio, ranked #363.

Hennion & Walsh Asset Management first reported a position in ALT in Q2 2024 and has held it in 10 quarters since. 7 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Hennion & Walsh Asset Management held 744,997 shares of Altimmune worth $2.13M as of Q3 2026.
  • Hennion & Walsh Asset Management bought 226,799 Altimmune shares in Q3 2026, an estimated $696K.
  • Altimmune made up 0.06% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #363 holding.
  • Hennion & Walsh Asset Management first reported a position in Altimmune in Q2 2024 and has held it in 10 quarters since.
  • 7 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.